Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancies

Explore clinical trials studying Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

134 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Malignancies trial results

Recruiting

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

NCT06756451

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • The First Affiliated Hospital of USTC Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
View all 16 locations
View Trial Details
Recruiting

Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab

NCT06465433

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • Petz Aladar County Teaching Hospital Győr, Hungary
  • Hospital S.M. Terni University of Perugia Terni, Italy
  • Samsung Medical Center Seoul, South Korea
  • Clinica Universitad de Navarra Pamplona, Spain
View Trial Details
Recruiting

ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)

NCT06378138

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Anhui Provincial Hospital (The First Affiliated Hospital of University of Science and Technology of China) Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
View all 53 locations
View Trial Details
Recruiting

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

NCT03557619

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +14 more
Locations
  • Duplicate_Henry Ford Health System /ID# 209090 Detroit, Michigan, United States
  • Dartmouth-Hitchcock Medical Center /ID# 169097 Lebanon, New Hampshire, United States
  • Gabrail Cancer Center Research /ID# 207039 Canton, Ohio, United States
  • Peter MacCallum Cancer Centre-East Melbourne /ID# 225247 East Melbourne, Victoria, Australia
View Trial Details

Related conditions